Posted on: March 7, 2018

St Mark’s Complex Cancer Service expanded with CRS and HIPEC

St Mark’s Hospital is proud to offer cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) as part of the Complex Cancer Clinic (CCC).  A significant number of patients with colorectal cancer will develop tumour spread inside the peritoneal cavity (termed colorectal peritoneal metastases – CPM), either at the time of initial diagnosis or during follow-up after primary treatment. Although the diagnosis of CPM was traditionally considered an incurable condition, CRS and HIPEC, combining extensive surgery to remove all tumour with intraperitoneal administration of heated chemotherapy, has evolved as an important management modality in selected patients with CPM, achieving long-term disease control and/or cure. Until recently, only three hospitals offered this service in the United Kingdom. Now, St. Mark’s Hospital has developed a CRS and HIPEC programme as part of its internationally renowned multidisciplinary Complex Cancer Clinic, uniquely combining expertise and experience in locally advanced and recurrent colorectal cancers with this exciting treatment strategy to offer disease control and potential cure to even more patients with advanced colorectal cancers.

For further information visit St. Mark’s Hospital’s Complex Cancer Clinic website.